These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19929747)

  • 1. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.
    Antoniu SA
    Biomarkers; 2010 Mar; 15(2):97-103. PubMed ID: 19929747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Gan WQ; Rousseau R;
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1207-14. PubMed ID: 18310480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pharmacological options in the therapy of COPD].
    Watz H; Kanniess F; Magnussen H
    Pneumologie; 2007 Jun; 61(6):365-73. PubMed ID: 17492578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perspectives in the management of chronic obstructive pulmonary disease].
    Sliwiński P
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():57-61. PubMed ID: 15524019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPD, a multicomponent disease: implications for management.
    Agusti AG
    Respir Med; 2005 Jun; 99(6):670-82. PubMed ID: 15878483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A; Ward NS
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
    Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety.
    Tashkin DP
    Curr Opin Pulm Med; 2010 Mar; 16(2):97-105. PubMed ID: 20019615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of COPD and future of anti-inflammatory therapy].
    Watz H; Bitter-Suermann S; Kanniess F; Magnussen H
    Med Klin (Munich); 2006 Apr; 101(4):283-92. PubMed ID: 16607484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians.
    Qaseem A; Snow V; Shekelle P; Sherif K; Wilt TJ; Weinberger S; Owens DK;
    Ann Intern Med; 2007 Nov; 147(9):633-8. PubMed ID: 17975186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium in chronic obstructive pulmonary disease.
    Pedone C; Incalzi RA
    N Engl J Med; 2009 Jan; 360(2):185; author reply 187. PubMed ID: 19129533
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Lacy P; York E; Man SF
    Am J Respir Crit Care Med; 2004 Oct; 170(7):760-5. PubMed ID: 15229100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy for chronic obstructive pulmonary disease in 2007.
    Ingenito EP
    Semin Thorac Cardiovasc Surg; 2007; 19(2):142-50. PubMed ID: 17870010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.